Trial	Phase	Sponsor	Dist.
Exploring Virtual Reality Adventure Training Exergaming	N/A	The University of Texas at Arlington	<1 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder	Phase 2	Reunion Neuroscience Inc	<1 mi
Mitigating PTSD-CUD After Sexual Assault	Phase 1/2	University of Nevada, Las Vegas	<1 mi
Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety	N/A	University of Texas at Austin	<1 mi
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy	N/A	University of Texas at Austin	<1 mi
Transcranial Photobiomodulation in Anxiety Disorders	N/A	Francisco Gonzalez-Lima, PhD	<1 mi
A Study of NTX-1472 in Social Anxiety Disorder	Phase 2	Newleos Therapeutics, Inc.	<1 mi
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.	Phase 3	Jasper A. Smits	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Wellness App for Sleep Disturbance in Hematological Cancer Patients	N/A	The University of Texas Health Science Center at San Antonio	<1 mi
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy	Phase 2	M.D. Anderson Cancer Center	<1 mi
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors	N/A	M.D. Anderson Cancer Center	<1 mi
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD	N/A	Baylor College of Medicine	<1 mi
ERP to Improve Functioning in Veterans With OCD	N/A	VA Office of Research and Development	<1 mi
A Neurosensory Account of Anxiety and Stress (Study 1)	N/A	The University of Texas Health Science Center, Houston	<1 mi
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer	Phase 2/3	M.D. Anderson Cancer Center	<1 mi
A Neurosensory Account of Anxiety and Stress (Study 2)	N/A	The University of Texas Health Science Center, Houston	<1 mi
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors	Phase 2	M.D. Anderson Cancer Center	<1 mi
Personalized Feedback Intervention for Latinx Drinkers With Anxiety	N/A	University of Houston	<1 mi
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety	N/A	Baylor College of Medicine	<1 mi
Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation	—	Baylor College of Medicine	<1 mi
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety	N/A	Michael J. Zvolensky, Ph.D.	<1 mi
Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use	N/A	VA Office of Research and Development	<1 mi
Application of Virtual Reality Technology to Treatment of Social Anxiety	N/A	The University of Texas Health Science Center, Houston	<1 mi
Stepped Care Treatment for Anxiety Resilience	N/A	Andrew Wiese	<1 mi
A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking	N/A	University of Houston	<1 mi
Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus	N/A	Christina Chianis Reed	<1 mi
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD	N/A	Baylor College of Medicine	<1 mi
Pilot Study of Virtual Reality Therapy for Students With Anxiety	N/A	The University of Texas Health Science Center, Houston	<1 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story	—	Baylor College of Medicine	<1 mi
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity	N/A	Deliberate Solutions Inc.	<1 mi
Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort	—	M.D. Anderson Cancer Center	<1 mi
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety	N/A	Baylor College of Medicine	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder	N/A	Nader Pouratian	<1 mi
Teen Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	<1 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
Targeting Social Function in Anxiety and Eating Disorders	N/A	University of Texas Southwestern Medical Center	<1 mi
Resilience in Adolescent Development	—	University of Texas Southwestern Medical Center	<1 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	<1 mi
Recovery Through Inspiration, Support, and Empowerment	N/A	University of Texas Southwestern Medical Center	<1 mi
Massage Therapy After Thoracic or Lumbar Surgery	N/A	Cook Children's Health Care System	2 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma	N/A	Memorial Sloan Kettering Cancer Center	6 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	13 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	13 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Phase 2	VistaGen Therapeutics, Inc.	18 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	18 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.